Seegene Mexico
상단으로
Contáctenos

Noticias sobre productos Puedes verificar las últimas informaciones de productos

  • Obtained CE-IVD marking and MFDS approval for Allplex™ PneumoBacter Assay

    Seegene has received CE-IVD mark under European Union on?In Vitro?Diagnostics Medical Devices, and received approval from Korean Ministry of Food and Drug Safety (MFDS) for Allplex™ PneumoBacter Assay. This assays?is a Multiplex Real-time PCR assay that detects and identifies 7 major respiratory bacteria associated with pneumonia. Based on Seegene's proprietary MuDT™ technology, this assay reports multiple Ct values of each pathogen in a single channel.

    Feb 20, 2019 Allplex™ PneumoBacter Assay

  • Obtained approval of MFDS for Allplex™ Respiratory Panel3

    Allplex™ Respiratory Panel 3 has received approval from Korean Ministry of Food and Drug Safety (MFDS).   This assay is a One-step real-time RT-PCR assay to detect simultaneously Bocavirus, Rhinovirus and three Coronaviruses (NL63, 229E, OC43) which cause respiratory infections in a single tube.

    Nov 24, 2016 Allplex™ Respiratory Panel 3

  • Obtained approval of MFDS for Allplex™ Respiratory Panel1

    Allplex™ Respiratory Panel 1 has received approval from Korean Ministry of Food and Drug Safety (MFDS). This assay is a One-step real-time RT-PCR assay to detect simultaneously Flu A, Flu B, RSV A and RSV B with Flu A subtyping in a single tube, which enables appropriate antiviral drug treatments

    Sep 01, 2016 Allplex™ Respiratory Panel 1

  • Obtained CE-IVD marking for Anyplex™ MERS-CoV Real-time Detection

    Anyplex™ MERS-CoV(upE) Real-time Detection,  Anyplex™ MERS-CoV (upE&orf1a) Real-time Detection Anyplex™ MERS-CoV (upE) Real-time Detection is a multiplex real-time one-step RT-PCR assay targeting upstream of the E protein gene (upE) for detection of MERS-CoV. The assay for the upE target is considered highly sensitive and is recommended for screening of MERS-CoV. Anyplex™ MERS-CoV (upE&orf1a) Real-time Detection is a multiplex real-time one-step RT-PCR assay targeting upstream of the E protein gene (upE) and orf1a gene for screening and confirmation of MERS-CoV.

    Jul 27, 2015 Anyplex™ MERS-CoV(upE & orf1a) Real-time Detection

  • Launched Allplex™ Respiratory Full Panel Assay

    Multiplex One-step RT Real-time PCR assay for reliable test results Allplex™ Respiratory Full Panel assay that composed of 4 different panels is a multiplex One-step RT Real-time PCR assay to detect and identify 16 viruses, 7 bacteria and 3 Flu A subtypes in patient’s specimens. Based on Seegene’s proprietary MuDT™ technology, this assay makes it possible to report individual Ct value of multiple pathogens in a single channel on real-time PCR instrument.Allplex™ Respiratory Full Panel AssayComprehensive assay for the detection and identification of 26 pathogens using One-step RT Real-time PCR

    Mar 23, 2015 Allplex™ Respiratory Panel Assays

  • Launched Anyplex™ II RB5 Detection

    Anyplex™ II RB5 Detection1Simultaneous detection of 5 Respiratory bacteriaAnyplex™ II RB5 Detection detects 5 respiratory bacteria in a single real-time PCR. Mycoplasma pneumoniae (MP), Chlamydophila pneumoniae (CP), and Legionella pneumophila (LP) are the most common causes of atypical pneumonia. As these atypical pathogens do not respond to β-lactam antimicrobial therapy commonly used for bacterial community-acquired pneumonia (CAP), accurate diagnosis beyond clinical assessment is critical for determination of optimal and effective treatment. Anyplex™ II RB5 Detection has been developed using Seegene's proprietary TOCE™ Technology as a rapid and simple multiplex molecular diagnostic to simultaneously detect and differentiate CAP-related pathogens with high sensitivity and specificity. In addition, Anyplex™ II RB5 also detects and differentiates two causative agents of whooping cough, the commonly detected Bordetella pertussis(BP) as well as the less common but vaccination-ineffective Bordetella parapertussis(BPP). In addition to enabling detection and differentiation of these 5 pathogens, responsible for the respiratory bacteria infections, Anyplex™ II RB5 providing valuable information for more precise diagnosis, effective treatment and clinical follow-up.

    Aug 31, 2012 Anyplex™Ⅱ RB5 Detection

  • Obtained CE-IVD marking for Anyplex™ II RV16 Detection

    Anyplex™ II  RV16 DetectionSimultaneous detection of 16 respiratory viruses Seegene's Anyplex™ II  RV16 Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    Dec 23, 2011 Anyplex™Ⅱ RV16 Detection

  • Simultaneous detection of 16 viruses using real-time instrumentation

    Anyplex™ RV16 Detection Multiple detection of 16 Respiratory virues using real-time instrumentation

    Oct 24, 2011 Anyplex™Ⅱ RV16 Detection